PFENYSEPharmaceutical PreparationsFiscal year ends December 31
PFIZER INC
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026
$29.44−0.14 (-0.47%)
Close on Oct 19, 2026
- Market cap
- $167.78B
- P/E (TTM)
- 38.7
- Dividend yield
- 5.84%
Pfizer statistics
Financials through Jun 28, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Pfizer | Industry median |
|---|---|---|
| Market Cap | $167.80B | $197.05M |
| Enterprise Value | $223.04B | $106.56M |
| PE Ratio | 38.74 | 20.52 |
| PS Ratio | 2.63 | 3.93 |
| PB Ratio | 1.97 | 2.14 |
| P/FCF Ratio | 15.28 | 18.25 |
| P/OCF Ratio | 12.52 | 13.78 |
Enterprise value
| Measure | Pfizer | Industry median |
|---|---|---|
| EV / Sales | 3.50 | 2.69 |
| EV / EBITDA | 16.53 | 14.86 |
| EV / FCF | 20.30 | 21.02 |
Income (trailing twelve months)
| Measure | Pfizer | Industry median |
|---|---|---|
| Revenue | $63.70B | $57.94M |
| Gross Profit | $46.61B | $90.47M |
| Pretax Income | $4.21B | -$14.45M |
| Net Income | $4.33B | -$22.46M |
| EBITDA | $13.49B | -$16.91M |
| EPS (Diluted) | $0.76 | -$0.83 |
Margins
| Measure | Pfizer | Industry median |
|---|---|---|
| Gross Margin | 73.2% | 52.3% |
| Pretax Margin | 6.61% | -13.0% |
| Profit Margin | 6.80% | -39.2% |
| EBITDA Margin | 21.2% | -31.3% |
| FCF Margin | 17.2% | -8.85% |
Returns
| Measure | Pfizer | Industry median |
|---|---|---|
| Return on Equity (ROE) | 4.98% | -53.1% |
| Return on Assets (ROA) | 2.13% | -41.0% |
Growth
| Measure | Pfizer | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.21% | 6.01% |
| Net Income Growth (YoY) | -59.7% | -37.7% |
| EPS Growth (YoY) | -59.6% | -29.2% |
| FCF Growth (YoY) | -11.7% | 2.34% |
| Revenue Growth (3Y CAGR) | -14.8% | 2.25% |
| Revenue Growth (5Y CAGR) | 8.48% | 6.42% |
| EPS Growth (3Y CAGR) | -37.1% | -0.17% |
| EPS Growth (5Y CAGR) | -3.56% | 3.77% |
Balance sheet
| Measure | Pfizer | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.26B | $62.42M |
| Total Debt | $63.19B | $120.13M |
| Net Cash (Debt) | -$54.94B | $15.68M |
| Net Cash Per Share | -$9.64 | $0.65 |
| Equity (Book Value) | $85.19B | $48.79M |
| Book Value Per Share | $14.95 | $1.36 |
| Tangible Book Value | -$33.28B | $23.06M |
| Working Capital | $8.71B | $75.77M |
Financial position
| Measure | Pfizer | Industry median |
|---|---|---|
| Current Ratio | 1.27 | 3.30 |
| Quick Ratio | 0.64 | 2.39 |
| Debt / Equity | 0.74 | 0.51 |
| Debt / EBITDA | 4.68 | 3.35 |
| Debt / FCF | 5.75 | 5.05 |
| Net Debt / EBITDA | 4.07 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Pfizer | Industry median |
|---|---|---|
| Operating Cash Flow | $13.40B | -$12.35M |
| Capital Expenditures | -$2.42B | -$1.06M |
| Free Cash Flow | $10.99B | -$20.28M |
| FCF Per Share | $1.93 | -$0.41 |
Efficiency
| Measure | Pfizer | Industry median |
|---|---|---|
| Asset Turnover | 0.31 | 0.38 |
| Inventory Turnover | 1.58 | 2.67 |
| Revenue Per Employee | $849.28K | $398.96K |
| Profits Per Employee | $57.76K | -$732.08K |
| Employee Count | 75,000 | 73 |
Dividends and yields
| Measure | Pfizer | Industry median |
|---|---|---|
| Earnings Yield | 2.58% | -21.2% |
| FCF Yield | 6.55% | -7.64% |
| Dividend Yield | 5.84% | 1.83% |
| Shareholder Yield | 5.84% | 0.00% |
| Dividend Per Share | $1.72 | $0.83 |
| Dividend Growth (YoY) | 1.78% | 2.37% |
| Years of Dividend Growth | 11 | 0 |
Shares
| Measure | Pfizer | Industry median |
|---|---|---|
| Shares Outstanding | 5,699,670,000 | 59,128,900 |
| Shares Change (YoY) | 0.18% | 11.1% |
| Float | 5,697,760,000 | 48,744,500 |
| Shares Held by Insiders | 0.03% | 11.8% |
| Shares Held by Institutions | 67.2% | 59.4% |
Taxes
| Measure | Pfizer | Industry median |
|---|---|---|
| Income Tax | -$164.00M | $91.50K |
| Effective Tax Rate | -3.90% | 20.6% |
Scores
| Measure | Pfizer | Industry median |
|---|---|---|
| Graham Number | $15.99 | $17.36 |
| Graham Upside | -45.7% | -45.5% |
| Altman Z-Score | 2.02 | 0.10 |
| Piotroski F-Score | 6 | 4 |
| Beneish M-Score | -2.52 | -2.62 |
Calculated by StockData from Pfizer's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.